1. A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial. (November 2022) Authors: Climent, Miguel A.; Font, Albert; Durán, Ignacio; Puente, Javier; José Méndez-Vidal, María; Sáez, María Isabel; Santander Lobera, Carmen; Ángel Arranz Arija, Jóse; González-del-Alba, Aranzazu; Sánchez-Hernandez, Alfredo; Juan Fita, Maria Jose; Esteban, Emilio; Alonso-Gordoa, Teresa; Mellado Gonza... Journal: European journal of cancer Issue: Volume 175(2022) Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of Spanish hospitals involved in the Quality Oncology Practice Initiative program. Issue 28 (1st October 2022) Authors: Garcia-Foncillas, Jesus; Lopez, Rafael; Camps, Carlos; Guillem, Vicente; Alonso, Jose Luis; Carrato, Alfredo; Martín, Nicole; Paz-Ares, Luis G.; Provencio, Mariano; Esteban, Emilio; Ayala, Francisco; Pérez-Segura, Pedro; Narbona, Javier; Bayo, Juan L.; Bessa, Maria; Gratal, Paula Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bilateral diffuse uveal melanocytic proliferation (BDUMP) as ocular toxicity from durvalumab in advanced renal carcinoma. (August 2022) Authors: Mihic Góngora, Luka; Santalla, Carla; Contreras Toledo, Débora; Díaz Vico, Tamara; Esteban, Emilio Journal: European journal of cancer Issue: Volume 171(2022) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program. (September 2014) Authors: Castellano, Daniel; Antón Aparicio, Luis M; Esteban, Emilio; Sánchez-Hernández, Alfredo; Germà, Jose Ramón; Batista, Norberto; Maroto, Pablo; Pérez-Valderrama, Begoña; Luque, Raquel; Méndez-Vidal, María José Journal: Expert opinion on drug safety Issue: Volume 13:Number 9(2014) Page Start: 1165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study. (June 2015) Authors: Muñoz-Langa, Jose; De Castro, Javier; Gascó, Pere; Sanchez, Alfredo; Esteban, Emilio; Gasent, Jose Manuel; Barneto, Isidoro; Montalar, Joaquin; Artal, Angel; Vidal, Sara Journal: Future oncology Issue: Volume 11:Number 11(2015) Page Start: 1665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study. (June 2015) Authors: Muñoz-Langa, Jose; De Castro, Javier; Gascó, Pere; Sanchez, Alfredo; Esteban, Emilio; Gasent, Jose Manuel; Barneto, Isidoro; Montalar, Joaquin; Artal, Angel; Vidal, Sara Journal: Future oncology Issue: Volume 11:Number 11(2015) Page Start: 1665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study. (June 2015) Authors: Muñoz-Langa, Jose; De Castro, Javier; Gascó, Pere; Sanchez, Alfredo; Esteban, Emilio; Gasent, Jose Manuel; Barneto, Isidoro; Montalar, Joaquin; Artal, Angel; Vidal, Sara Journal: Future oncology Issue: Volume 11:Number 11(2015) Page Start: 1665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies. Issue 6 (3rd June 2018) Authors: Castellano, Daniel; Maroto, José Pablo; Espinosa, Enrique; Grande, Enrique; Bolós, M Victoria; Llinares, Julia; Esteban, Emilio; González del Alba, Aranzazu; Climent, Miguel Angel; Arranz, Jose Angel; Méndez, Mª José; Fernández Parra, Eva; Antón-Aparicio, Luis; Bayona, Cristina; Gallegos, Isabel;... Journal: Expert opinion on drug safety Issue: Volume 17:Issue 6(2018) Page Start: 573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study. Issue 1 (December 2016) Authors: Lainez, Nuria; García-Donas, Jesús; Esteban, Emilio; Puente, Javier; Sáez, M.; Gallardo, Enrique; Pinto-Marín, Álvaro; Vázquez-Estévez, Sergio; León, Luis; García-Carbonero, Icíar; Suárez-Rodríguez, Cristina; Molins, Carmen; Climent-Duran, Miguel; Lázaro-Quintela, Martín; González del Alba, Aranz... Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Management of the adverse events of afatinib: a consensus of the recommendations of the Spanish expert panel. (January 2015) Authors: Arriola, Edurne; Reguart, Noemi; Artal, Angel; Cobo, Manuel; García-Campelo, Rosario; Esteban, Emilio; Rodríguez, Mari Carmen; García-Muret, Maria Pilar Journal: Future oncology Issue: Volume 11:Number 2(2015) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗